Open AccessFragile Endothelium and Brain Dysregulated Neurochemical Activity in COVID-19
Author(s) -
Abdulrahman Alharthy,
Fahad Faqihi,
Ziad A. Memish,
Dimitrios Karakitsos
Publication year - 2020
Publication title -
acs chemical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.158
H-Index - 69
ISSN - 1948-7193
DOI - 10.1021/acschemneuro.0c00437
Subject(s) - neurochemical , cardiomyopathy , medicine , endothelium , endothelial dysfunction , neuroinflammation , immune dysregulation , immune system , neuroscience , heart failure , inflammation , immunology , psychology
Immune system and renin-angiotensin-aldosterone system dysregulation with associated cytokine release syndrome may be a key feature of early stage of SARS-CoV-2 organotropism and infection. Following viral mediated brain injury, dysregulated neurochemical activity may cause neurogenic stress cardiomyopathy, which is characterized by transient myocardial dysfunction and arrhythmias. Cardiomyopathy along with acute acute inflammatory thromboembolism and endotheliitis (fragile endothelium) might at least partially explain the underlying mechanisms of rapidly evolving life-threatening COVID-19. Further studies are clearly required to explore these complex pathologies.